Cargando…
Correlation between structural heart disease and cardiac SARS-CoV-2 manifestations
BACKGROUND: The prognosis of COVID-19 patients with cardiac involvement is unfavorable and it remains unknown which patients are at risk. The virus enters cells via its receptor angiotensin-converting enzyme 2 (ACE2). Myocardial ACE2 expression is increased in structural heart disease (SHD). We, the...
Autores principales: | Nägele, Felix, Graber, Michael, Hirsch, Jakob, Pölzl, Leo, Sahanic, Sabina, Fiegl, Manuel, Hau, Dominik, Engler, Clemens, Lechner, Sophia, Stalder, Anna Katharina, Mertz, Kirsten D., Haslbauer, Jasmin D., Tzankov, Alexandar, Grimm, Michael, Tancevski, Ivan, Holfeld, Johannes, Gollmann-Tepeköylü, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651888/ https://www.ncbi.nlm.nih.gov/pubmed/36369278 http://dx.doi.org/10.1038/s43856-022-00204-6 |
Ejemplares similares
-
Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022) -
Lockdown surgery: the impact of coronavirus disease 2019 measures on cardiac cases
por: Nägele, Felix, et al.
Publicado: (2022) -
Defining a therapeutic range for regeneration of ischemic myocardium via shock waves
por: Pölzl, Leo, et al.
Publicado: (2021) -
The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza
por: Sahanic, Sabina, et al.
Publicado: (2021) -
Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial
por: Pölzl, Leo, et al.
Publicado: (2020)